Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.095
+0.0953.17%
Volume:84.20K
Turnover:253.59K
Market Cap:1.33B
PE:-5.84
High:3.095
Open:2.960
Low:2.925
Close:3.000
52wk High:16.800
52wk Low:2.800
Shares:429.00M
HK Float Shares:418.00M
Volume Ratio:0.15
T/O Rate:0.02%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.530
ROE:-29.87%
ROA:-13.80%
PB:1.44
PE(LYR):-5.84
PS:7.41

Loading ...

IMMUNEONCO-B Implements ESOP-Driven Capital Injection into Non-Oncology Subsidiary, Adjusts Shareholding Structure

Bulletin Express
·
Jul 31

ImmuneOnco Clarifies Subsidiary Capital Increase as Employee Incentive Scheme Via ESOP Platform

Reuters
·
Jul 31

ImmuneOnco Completes HKD 0.19 Million H-Share Buyback, Issued Share Count Trimmed to 418.46 Million

Bulletin Express
·
Jul 24

Immuneonco Files HKEX Next-day Disclosure Return Reporting Share Repurchase for Treasury Shares

Reuters
·
Jul 24

IMMUNEONCO-B buys back 49,000 H-shares, treasury stock rises to 1.96 million

Bulletin Express
·
Jul 23

IMMUNEONCO-B (01541) Allocates HK$165,900 for Buyback of 49,000 Shares on July 23

Stock News
·
Jul 23

Immuneonco Files HKEX Next-day Disclosure Return on Share Repurchase Cancellation

Reuters
·
Jul 23

ImmuneOnco completes HK$0.22 million share repurchase; treasury shares rise to 1.91 million

Bulletin Express
·
Jul 22

Immuneonco Files HKEX Next-day Disclosure Return on Share Repurchase/cancellation

Reuters
·
Jul 22

IMMUNEONCO-B repurchases 63,800 H shares, treasury stock rises to 1.85 million

Bulletin Express
·
Jul 17

IMMUNEONCO-B Repurchases Shares for HK$220,400

Stock News
·
Jul 17

Immuneonco Files HKEX Next-day Disclosure Return After Share Repurchase at HKD 3.59-3.39

Reuters
·
Jul 17

Initiating Coverage on IMMUNEONCO-B with a Buy Rating and HK$6.28 Target Price

Stock News
·
Jul 13

ImmuneOnco Biopharma Doses First Patient in Phase 2/3 IgG4 Disease Trial

MT Newswires Live
·
Jul 10

ImmuneOnco: First Patient Dosed in Phase II/III Study of Dual-Targeting Antibody IMM0306 for IgG4-Related Disease

Bulletin Express
·
Jul 10

IMMUNEONCO-B (01541) Administers First Dose in Phase II/III Trial for IgG4-Related Disease Treatment

Stock News
·
Jul 10

IMMUNEONCO-B repurchases 63.60 K H-shares on 9 July 2026, treasury stock rises to 1.79 million

Bulletin Express
·
Jul 09

IMMUNEONCO-B Repurchases Shares for HK$201,400 on July 8

Stock News
·
Jul 08

Immuneonco Files HKEX Next-day Disclosure Return After Share Repurchase

Reuters
·
Jul 08

IMMUNEONCO-B Repurchases 91,800 H Shares; Treasury Holding Rises to 1.67 Million

Bulletin Express
·
Jul 07